Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
FCGR3A encodes a receptor for the Fc portion of immunoglobulin G, and it is involved in the removal of antigen-antibody complexes from the circulation, as well as other other antibody-dependent responses. Additionally we are shipping FCGR3A Proteins (25) and FCGR3A Kits (14) and many more products for this protein.
Showing 10 out of 297 products:
Human Polyclonal FCGR3A Primary Antibody for WB - ABIN657457
Dornan, Spleiss, Yeh, Duchateau-Nguyen, Dufour, Zhi, Robak, Moiseev, Dmoszynska, Solal-Celigny, Warzocha, Loscertales, Catalano, Afanasiev, Larratt, Rossiev, Bence-Bruckler, Geisler, Montillo, Wenger, Weisser: Effect of FCGR2A and FCGR3A variants on CLL outcome. in Blood 2010
Show all 2 references for ABIN657457
Human Monoclonal FCGR3A Primary Antibody for FACS, IHC (p) - ABIN1688969
Romano, Kusio-Kobialka, Foukas, Baumgaertner, Meyer, Ballabeni, Michielin, Weide, Romero, Speiser: Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients. in Proceedings of the National Academy of Sciences of the United States of America 2015
FCGR3A expression is significantly upregulated in human masticatory mucosa during wound healing
Our findings indicate that CD16 (show CD16 Antibodies) 158F>V polymorphism may contribute to the increased risk of Idiopathic Thrombocytopenic Purpura, whereas CD32 (show FCGR2B Antibodies) 131H>R polymorphism may not be an important risk factor for Idiopathic Thrombocytopenic Purpura.
this study shows that genetic polymorphisms located within an enhancer FCGR3A influence NK cell-mediated antibody-dependent cellular cytotoxicity
Anti-platelet drugs exert an immunomodulatory action by counteracting CD14 (show NDUFA2 Antibodies)(high)CD16 (show CD16 Antibodies)(+) monocyte increase under pro-inflammatory conditions, with this effect being dependent on the amplitude of P-selectin (show SELP Antibodies) reduction.
analysis of natural killer cell markers in renal transplantation that have roles in acute rejection reveals that CD56 and CD57 are increased in the interstitial compartment in donor-specific antibody (DSA)-negative biopsies from patients with acute antibody-mediated rejection without C4d, and CD16 is increased in the glomerular compartment in DSA-positive biopsies
FCGR2A/FCGR3A (show CD16 Antibodies)-related immune disorder might contribute to the etiology of Takayasu arteritis.
Studies suggest that the Fc gamma receptor IIIA (FCGR3A) 158 V/F polymorphism can predict the treatment response to rituximab-based chemotherapy in non-Hodgkin lymphoma (NHL (show RTEL1 Antibodies)) patients.
The incidences of the FCGR3A-158 variants VV, VF, and FF for nine patients with relapse were 0 (0 %), 8 (89 %), and 1 (11 %) compared to 13 (11 %), 61 (52 %), and 44 (37 %) in the 118 patients without relapse.
Lower copy numbers (=3) of FCGR3A (show CD16 Antibodies) and FCGR3B (show CD16 Antibodies) genes confer a risk factor for ankylosing spondylitis susceptibility.
This metaanalysis indicates that polymorphisms in the pathways of immune complex clearance, such as the FcgammaRIIIa, FcgammaRIIIb, and ITGAM (show ITGAM Antibodies) genotypes, are potential susceptibility genes for neuropsychiatric systemic lupus erythematosus.
This gene encodes a receptor for the Fc portion of immunoglobulin G, and it is involved in the removal of antigen-antibody complexes from the circulation, as well as other other antibody-dependent responses. This gene (FCGR3A) is highly similar to another nearby gene (FCGR3B) located on chromosome 1. The receptor encoded by this gene is expressed on natural killer (NK) cells as an integral membrane glycoprotein anchored through a transmembrane peptide, whereas FCGR3B is expressed on polymorphonuclear neutrophils (PMN) where the receptor is anchored through a phosphatidylinositol (PI) linkage. Mutations in this gene have been linked to susceptibility to recurrent viral infections, susceptibility to systemic lupus erythematosus, and alloimmune neonatal neutropenia. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
, Fc fragment of IgG, low affinity III, receptor for (CD16)
, Fc gamma receptor III-A
, Fc-gamma RIII-alpha
, Fc-gamma RIIIa
, Fc-gamma receptor III-2 (CD 16)
, Fc-gamma receptor IIIb (CD16)
, fc-gamma RIII
, igG Fc receptor III-2
, immunoglobulin G Fc receptor III
, low affinity immunoglobulin gamma Fc region receptor III-A
, neutrophil-specific antigen NA